AKBA - Akebia Therapeutics, Inc.
IEX Last Trade
1.955
0.015 0.767%
Share volume: 67,767
Last Updated: Fri 27 Dec 2024 08:29:43 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.94
0.02
0.77%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2023-03-31 | 2022-12-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q1 2023 | Q4 2022 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-05-08 | 2023-08-28 | 2023-08-28 | 2023-11-08 | 2024-03-14 | 2024-05-09 | |
| Total revenue | 126.759 M | 48.964 M | 40.127 M | 55.062 M | 56.376 M | 42.046 M | 56.074 M | 32.607 M | |
| Cost of revenue | 9.589 M | 28.936 M | 10.473 M | -11.332 M | 8.273 M | 8.998 M | 10.363 M | 2.594 M | |
| Gross profit | 117.170 M | 20.028 M | 29.654 M | 66.394 M | 48.103 M | 33.048 M | 45.711 M | 30.013 M | |
| -82.91% | 48.06% | 123.90% | -27.55% | -31.30% | 38.32% | -34.34% | |||
| Operating expenses | 58.834 M | 58.268 M | 44.907 M | 63.325 M | 47.233 M | 36.040 M | 35.132 M | 35.169 M | |
| Selling general and admin | 32.807 M | 30.918 M | 25.221 M | 30.549 M | 27.036 M | 22.710 M | 25.266 M | 25.438 M | |
| Research and development | 26.027 M | 27.350 M | 19.686 M | 32.776 M | 20.197 M | 13.330 M | 9.866 M | 9.731 M | |
| Total expenses | 78.326 M | 96.958 M | 64.959 M | 61.854 M | 65.466 M | 54.913 M | 55.360 M | 47.485 M | |
| 23.79% | -33.00% | -4.78% | 5.84% | -16.12% | 0.81% | -14.23% | |||
| Operating income | 48.433 M | -47.994 M | -24.832 M | -6.792 M | -9.090 M | -12.867 M | 714.000 K | -14.878 M | |
| Ebit | 48.433 M | -47.994 M | -24.832 M | -6.792 M | -9.090 M | -12.867 M | 714.000 K | -14.878 M | |
| Pretax income | 29.276 M | -51.865 M | -26.217 M | -9.216 M | -11.172 M | -14.489 M | -47.000 K | -17.985 M | |
| -277.16% | -49.45% | -64.85% | 21.22% | 29.69% | -99.68% | 38,165.96% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 29.276 M | -51.865 M | -26.217 M | -9.216 M | -11.172 M | -14.489 M | -47.000 K | -17.985 M | |
| -277.16% | 49.45% | 64.85% | -21.22% | -29.69% | 99.68% | -38,165.96% | |||
| Net income | 29.276 M | -51.865 M | -26.217 M | -9.216 M | -11.172 M | -14.489 M | -47.000 K | -17.985 M | |
| -277.16% | 49.45% | 64.85% | -21.22% | -29.69% | 99.68% | -38,165.96% |